Home  

 

 

 

 

NeuroScan

 

 

 

 

 

 

  |    EMG / PE    |    VÍDEO EEG    |    NEUROSCAN    |    SONO    |    QST    |    CPAP    |    AGULHAS    |     PORTAPRES     | 

English

Español

 

Home  Home      Telefone   + 55 11 3662-0762    Fax   + 55 11 3825-7311    E-mail   biolink@biolinkbr.com    E-mail   biolinkbr@gmail.com

    : : Quem somos
 
    : : Equipamentos
    • EEG  
    • EEG Ambulatorial
    • Vídeo EEG
    • PSG
    • PSG Ambulatorial
    • EMG / PE
    • IOM
    • Neuroscam
    • Monitor
    • Thermode
    • GSA
    • TSA-II
    • VSA-3000
    • Patway
    • ThermalStim
    • DuetSystem
    • CPAP
    • Estimuladores
    • Holter de EEG
    • Finometer
    • Portapres
    • MAPA
    • Biofeedback
    : :  NEUROSCAN
    • EEG/PE Research
    • ESI
    • MAGLINK
    • Nuamps
    • SCAN 4.3
    • SCAN Nuamps Ex
    • Stim
    • Stim2
    • SynAmps
    • SynAmps2
    • ToolBox
    • Curry 5.0
    Source 2.0
    : : Acessórios
    • Faixa torácica
    • Eletrodo EEG
    • Pasta EEG
    • Termistor
    • Cânula  Resp.
    • Microfone
    • Sensor de Ronco
    • Máscara CPAP
    : : BioScience
      Stellate
    • EEG
    • Vídeo EEG
    Cirurgia Epilepsia
    Polissonografia
    : : Digitimer
    • Digitimer D185
    • Acessórios
    : :  Agulhas
    • Botox
    • Monopolar
    • Neurólise
    • DuetSystem
    • Subdermal
    : : BREAS
    • CPAP
    • CPAP iSleep 10
    • CPAP iSleep 20
    • CPAP PV10i
    • Máscara Nasal
    Máscara Oral
    Máscara Full Face
    Máscara Direct
    : : Estimuladores
    • Neuroloc I
    • Neuroloc II
    • Neuro TOF I
    • Neuro TOF II
    : : FMS
    Portapres
    Finometer
    Beatscope
    : : Medoc
    • Patway
    • TSA-II
    • GSA
    • VSA-3000
    • Diabetes
    • Dor Crônica
    • FSD
    • Hanseniase
    : : Neurolinks
    Eletromiografia
    Estimuladores
    Epilepsia
    Sono
    Sleep Glossary
    : : Outros Links
    • Biolink
    • Biolink1
    • Biolink2
    • Biolink3
    • Biolink4
    • Biolink5
    • Biolink6
    • Biolink7
    • Biolink8
    • Biolink9
Pelvic Floor/ Female Sexual Dysfunction (FSD)

Characterizing FSD
Female Sexual Dysfunction (FSD) is age-related, progressive and highly common affecting 30-50% of women. For post-menopausal women, the occurrence rate of FSD may be as high as 63%. FSD is currently thought to represent a spectrum of sexual disorders with both psychogenic and organic causes that have been classified into four major categories: desire, arousal, orgasmic and sexual pain disorders. Based on the National Health and Social Life Survey of 1,749 women, 43% experienced sexual dysfunction (compared with 31% of men). Female sexual dysfunction has clearly become an important women's health issue that affects the quality of life of many female patients.

Organic FSD - a Timely Issue
A number of factors contribute to the growing problem of female sexual dysfunction; leading among them are the neurological disorders, surgeries and childbirth techniques that destroy the delicate nerve networks that connect female sexual organs to the brain. For instance, most hysterectomies are performed without attempts to prevent damage to nerves in the area. Organic Female Sexual Dysfunction is now a timely and hot issue and a major focus of research and therapeutic development. Currently, there are only a small number of clinical diagnostic tests available for assessing such organic dysfunction. Growing television, radio and print media reports are bringing increasing physician, industry and consumer attention to this subject.

GSA GenitoSensory Analyzer Assessing Pelvic Floor Sensory Functions
In cooperation with leading neurologists and urologists in the USA, Europe and Israel, medoc has developed a system and methodology for quantitative assessment of pelvic floor sensory functions. The GSA GenitoSensory Analyzer system can be also applied as a valuable, new diagnostic tool for assessment of neural dysfunction intra and peri-vaginally, including clitoral sensation. The GSA GenitoSensory Analyzer assists in determining whether FSD is caused by physiological or psychological reasons, as well as assist in therapy selection and monitoring progression and patients' recovery. The system can also supply objective documentation as well as a basis to argue for continued coverage with insurance carriers. As thermal and autonomic fibers are small-fibers, thermal testing with the GSA GenitoSensory Analyzer can be employed as a means of inferring diagnostic information concerning autonomic response. Thermal testing may provide a sensitive measure in autonomic disorders, such as with neurogenic bladder, orthostasis and impotence (see below).

Assessing Sensory Fibers
In the context of FSD, the assessment of the large myelinated sensory fibers - those that convey the sensations of touch, vibration position and light pressure – may be very important. Their dysfunction could affect the sensory modalities most important for female sexual function. The thresholds for vibration detection represent the functioning of these large sensory fibers and their central (CNS) connections. The thermal senses, warm and cold, are served by small nerve fibers. The thresholds for cold and warm detection represent the functioning of these small sensory fibers, and their central connections.

Neurogenic Male Impotence
Neurogenic Male Impotence can be evaluated successfully with the GSA GenitoSensory Analyzer as well, assisting in the differential diagnosis of neurogenic vs. psychogenic impotence. Neurogenic impotence is associated with failure of autonomic, small-caliber nerve fibers, as can be assessed with the GSA. Several studies (Robinson et al, 1987, Fowler et al, 1988) evaluated thermal sensation of penile skin in diabetic impotent patients, finding a high percentage of abnormality of thermal thresholds. The VSA-3000 Vibratory Sensory Analyzer provides a low cost computerized method to assess large fiber function, providing a computerized and more precise alternative to the Biothesiometer, which is commonly used in the evaluation of neurogenic impotence (Goldstein et al, 1988). Lefaucheur et al (2000) investigated penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. The authors concluded: "This study highlights the occurrence of penile small nerve fiber damage following TURP and supports the hypothesis of neurogenic damage as the primary cause of post-operative erectile dysfunction". In Yarnitsky et al's 1996 paper published in the JOURNAL OF UROLOGY, the authors concluded: "Penile thermal thresholds are repeatable and can be used as a valid diagnostic tool to assess somatic small fiber function in patients with lower urinary tract disorders". Xin et al (1996) concluded: "Patients with primary premature ejaculation have penile hypersensitivity, which provides further implications for an organic basis of premature ejaculation."

Clinical and Research Activity into Chronic Pelvic Pain
Chronic Pelvic Pain is an area of growing clinical and research activity in which the TSA-II NeuroSensory Analyzer has been playing an active role. The TSA and GSA GenitoSensory Analyzer allows for intra and peri-vaginal assessment of both small caliber A-delta and C-fiber function. Assessment of sensory deficits through cold and warm threshold testing, as well as the evaluation of positive sensory phenomena through cold and heat-pain threshold and suprathreshold testing is available. medoc systems also facilitate the investigation of Windup and Temporal Summation and the role this may play in certain chronic pain conditions. Utilizing the medoc system in the study of chronic pelvic pain patients, Lee et al (2000) concluded: "Patients with Chronic Pelvic Pain Syndrome (CPPS) have an altered sensation of perineal pain affected by heat, which may represent a C-fiber mediated effect".